World Library  
Flag as Inappropriate
Email this Article

Diisopropyl fluorophosphate

Article Id: WHEBN0003207188
Reproduction Date:

Title: Diisopropyl fluorophosphate  
Author: World Heritage Encyclopedia
Language: English
Subject: Demecarium bromide, Aceclidine, Ethoprop, Chlorethoxyfos, Dicrotophos
Collection: Acetylcholinesterase Inhibitors, Neurotoxins, Ophthalmology Drugs, Organophosphate Insecticides, Phosphorofluoridates
Publisher: World Heritage Encyclopedia

Diisopropyl fluorophosphate

Diisopropyl fluorophosphate
Systematic (IUPAC) name
bis(propan-2-yl) fluorophosphonate
CAS Registry Number  Y
ATC code S01
PubChem CID:
DrugBank  Y
ChemSpider  Y
Chemical data
Formula C6H14FO3P
Molecular mass 184.146 g/mol
Physical data
Melting point −82 °C (−116 °F)
Boiling point 183 °C (361 °F) 1013 mbar

Diisopropyl fluorophosphate (DFP, DIFP, diisopropyl phosphorofluoridate) is an oily, colorless liquid with the chemical formula C6H14FO3P. It is used in medicine and as an insecticide. It is stable, but undergoes hydrolysis when subjected to moisture, producing hydrofluoric acid. It is known also under names Difluorophate, Diflupyl, Diflurphate, Dyflos, Dyphlos, Fluropryl, Fluostigmine, isofluorophate, isofluorphate, Neoglaucit, PF-3, PF3, T-1703, TL 466, and others.


  • Uses in medicine 1
  • Uses as toxin 2
  • Chemistry 3
  • See also 4
  • References 5
  • External links 6

Uses in medicine

Diisopropyl fluorophosphate is a parasympathomimetic drug delayed peripheral neuropathy. It is known as fluostigmine and Dyflos in such uses.

Uses as toxin

Reaction of the DIFP with a serine protease

The marked toxicity of esters of monofluorophosphoric acid was discovered in 1932, when Willy Lange and his PhD student Gerda von Krueger prepared the methyl, ethyl, n-propyl, and n-butyl esters and incidentally experienced their toxic effects. Another homologue of this series of esters, Diisopropyl fluorophosphate, was developed by British scientist Bernard Charles Saunders. On his search for compounds to be used as chemical warfare agents, Saunders was inspired by the report by Lange and Krueger and decided to prepare the new homologue which he labeled PF-3. It was much less effective as a chemical weapon than the G series agents. It was often mixed with mustard gas, forming a more effective mixture with significantly lower melting point, resulting in an agent suitable for use in cold weather.

Protease-Inhibitor Complex.
Crystal structure of Herpes Simplex Virus Protease/Inhibitor (DFP) complex. The active site serine (yellow) has undergone phosphonylation resulting in irreversible inhibition. Rendered from PDB 1AT3.

In military research, due to its physical and chemical similarities and comparatively low toxicity, it is used as a simulant of G-agents (GA, GB, GD, and GF).

Diisopropyl fluorophosphate is a very potent neurotoxin. Its LD50 in rats is 1.3 mg/kg. It combines with the amino acid serine at the active site of the enzyme acetylcholinesterase,[1] an enzyme that deactivates the neurotransmitter acetylcholine. Neurotransmitters are needed to continue the passage of nerve impulses from one neuron to another across the synapse. Once the impulse has been transmitted, acetylcholinesterase functions to deactivate the acetylcholine almost immediately by breaking it down. If the enzyme is inhibited, acetylcholine accumulates and nerve impulses cannot be stopped, causing prolonged muscle contraction. Paralysis occurs and death may result since the respiratory muscles are affected.

DFP also inhibits some proteases. It is a useful additive for protein or cell isolation procedure.


Isoflurophate, the di-iso-propyl ester of fluorophosphoric acid, is made by reacting isopropyl alcohol with phosphorus trichloride, forming di-iso-propylphosphite, which is chlorinated and further reacted with sodium fluoride to replace the chlorine atom with fluorine, thus giving isofluorophate.

  • E.E. Hardy, G.M. Kosoloapoff, U.S. Patent 2,409,039 (1946).

See also

  • MAFP (methoxy arachidonoylfluorophosphonate), a mechanistically related inhibitor


  1. ^ Millard, C.B.; Kryger, G.; Ordentlich, A.; Greenblatt, H.M.; Harel, M.; Raves, M.L.; Segall, Y.; Barak, D.; Shafferman, A.; Silman, I.; Sussman, J.L (1999). "Crystal structures of phosphylated acetylcholinesterase: Nerve agent reaction products at atomic resolution". Biochemistry 38 (22): 7032–9.  
  • Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company.  
  • Meiers, P. (2006). "History of the fluorophosphates". 

External links

  • The MEROPS online database for peptidases and their inhibitors: DFP
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.